Clinical trial
Evaluating the Impact of Ciprofol on Oxygenator Performance in Patients Undergoing Extracorporeal Membrane Oxygenation: A Single-Center Randomized Controlled Trial (CIP-OXY Study)
NCT06934811 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wannan Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of Ciprofol on Oxygenator Performance in Patients Undergoing Extracorporeal Membrane Oxygenation: A Single-Center Randomized Controlled Trial (CIP-OXY Study)
- Lead sponsor
- First Affiliated Hospital of Wannan Medical College
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- May 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ards (acute respiratory distress syndrome), ecmo and acute mi, ecmo treatment, respiratory failure patients treated with ecmo, shock, cardiogenic